<DOC>
	<DOCNO>NCT00894959</DOCNO>
	<brief_summary>The objective study verify , randomize , single-blind , multicentre , parallel comparative study , effectiveness heparin sodium porcine origin patient undergoing heart surgery require aid cardiopulmonary bypass , control hemostasis surgery , base strength marker coagulation TCA , TTPA , Anti-Xa , heparin bioavailable loss excessive blood ( bleed ) end surgery .</brief_summary>
	<brief_title>Efficacy Safety Sodium Heparin Patients</brief_title>
	<detailed_description />
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Patients agree aspect study sign FICT ; Patients sex ; Patients age 18 year ; Patients cardiac surgery require movement ; AND Extracorporeal . Patients hematological disorder compromise surgical change ( eg myeloproliferative syndrome , anemia Hb &lt; 11.0 g / dL , Platelets &lt; 150,000 mm3 ) ; Patients disorder hemostasis ( INR &gt; 1.40 ) ( rTTPA &gt; 1.40 ) ; Patients renal dysfunction ( creatinine &gt; 1.50 ) ; Patients deep hyperthermia ; Liver disease ( AST ALT &gt; 2 time reference value ) ; Patients history allergy heparin protamine ; Patients history heparininduced thrombocytopenia ; Tables infection ( eg endocarditis , infection immune human ( HIV ) , hepatitis B C , septicemia pneumonia ) ; Reoperations ; Use antiplatelet ( clopidogrel ticlopidine ) less 7 day ; Use acetylsalicylic acid le 5 day ; Use low molecular weight heparin le 24 hour ; OR Use nonfractioned heparin le 12 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>heparin cardiac surgery</keyword>
</DOC>